Company Overview and News

 
Arizona Mining Obtains Final Order for Plan of Arrangement

2018-08-03 globenewswire
VANCOUVER, British Columbia, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX: AZ) (“Arizona Mining” or the “Company”) announces that it has obtained a final order from the Supreme Court of British Columbia (the “Final Order”) approving the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”) whereby South32 Limited (“South32”), will acquire all of the issued and outstanding common shares of the Company (“Common Shares”) not already owned by South32 or its affiliates for C$6.
AZ SOUHY SHTLF

 
Arizona Mining Shareholders Approve Plan of Arrangement

2018-08-02 globenewswire
VANCOUVER, British Columbia, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX: AZ) (“Arizona Mining” or the “Company”) announces the voting results from today’s special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares of the Company (the “Common Shares”). At the Meeting, the Shareholders were asked to consider and, if deemed advisable, pass a special resolution (the “Arrangement Resolution”) approving a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”) whereby South32 Limited (“South32”), will acquire all of the issued and outstanding Common Shares not already owned by South32 or its affiliates for C$6.
AZ SOUHY SHTLF

 
Arizona Mining Receives Interim Order for Plan of Arrangement - Shareholder Meeting Set for August 2, 2018

2018-07-03 globenewswire
VANCOUVER, British Columbia, July 03, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX:AZ) (“Arizona Mining” or the “Company”) announced that it obtained an interim order of the Supreme Court of British Columbia on June 29, 2018 providing for, among other things, the holding of a special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares”) of the Company to consider the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”) pursuant to which South32 Limited (“South32”) will acquire all of the Company’s outstanding Common Shares not already owned by South32 and its affiliates for C$6.
AZ SOUHY SHTLF

20
Pro Rata - June 18, 2018 - Axios

2018-06-18 axios
Federal prosecutors on Friday charged Theranos founder Elizabeth Holmes and former Theranos president Sunny Balwani with 11 counts of criminally defrauding investors, patients and doctors.
VM LYB S32 BOKF COBZ AZ LALWF MS

4
South32 to Acquire Arizona Mining in Agreed All Cash Offer

2018-06-17 globenewswire
VANCOUVER, British Columbia and PERTH, Australia, June 17, 2018 (GLOBE NEWSWIRE) -- South32 Limited (ASX:S32) (JSE:S32) (LSE:S32) (ADR:SOUHY) (South32) and Arizona Mining Inc. (TSX:AZ) (Arizona Mining) announced today that they have entered into an agreement for South32 to acquire the remaining 83 per cent of issued and outstanding shares of Arizona Mining via a plan of arrangement, representing a fully funded, all cash offer of US$1.
AZ MALRY SOUHY MALRF S32 S32 MIN SHTLF

 
Arizona Mining Announces AGM Results

2018-06-15 globenewswire
VANCOUVER, British Columbia, June 15, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX:AZ) (“Arizona Mining” or the “Company”) is pleased to report the results from its 2018 annual general and special meeting of shareholders held today. Shareholders voted in favour of all items put forward by the Board of Directors and management.
AZ

 
Arizona Mining Reports Significant High-Grade Drill Results in a New Copper-Rich Zone at the Taylor Project

2018-05-22 globenewswire
VANCOUVER, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX:AZ) (“Arizona Mining” or the “Company”) announces robust results for two drill holes from the current program focused on expansion of the Taylor Deeps Zone (“TDS”) located on its 100%-owned Hermosa Project in Santa Cruz County, Arizona. The drill holes highlighted in this release are successful step-out exploration drill holes highlighting the continued potential for resource growth, increased zinc-lead-silver grades and significant copper grades associated with the high-grade Taylor Deeps Zone.
AZ

 
Arizona Mining to Begin Twin Declines at Taylor Project Ahead of Schedule

2018-03-26 globenewswire
VANCOUVER, British Columbia, March 26, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX:AZ) (“Arizona Mining” or the “Company”) announces that it has received all required permits and notices for twin exploration declines at the Taylor zinc-lead-silver project located on its 100%-owned Hermosa Project in Santa Cruz County, Arizona.
AZ

 
Arizona Mining Reports Significant Additional High-Grade Drill Results From the Taylor Project

2018-03-22 globenewswire
VANCOUVER, B.C., March 22, 2018 (GLOBE NEWSWIRE) -- Arizona Mining Inc. (TSX:AZ) (“Arizona Mining” or the “Company”) announces strong results for three drill holes from the current program focused on expansion of the Taylor Sulfide Zone (“TS”) and Taylor Deeps Zone (“TDS”) located on its 100%-owned Hermosa-Taylor Project in Santa Cruz County, Arizona. The drill holes highlighted in this release are successful infill drill holes highlighting the continued potential for resource growth and increased grades, as distinct from the Updated Preliminary Economic Assessment (“PEA”) (see Press Release dated January 16, 2018).
AZ

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TSX:AZ / Az Mining Inc on message board site Silicon Investor.

Amazon.com, Inc. (AMZN) Amazon.com, Inc. (AMZN) Amazon.com, Inc. (AMZN) The Brazil Board The Brazil Board The Brazil Board
Canu0027t Beat Amazon! Canu0027t Beat Amazon! Canu0027t Beat Amazon! Amazon short Amazon short Amazon short
AZN: AstraZeneca PLC AZN: AstraZeneca PLC AZN: AstraZeneca PLC Amazon vs. Alibaba Amazon vs. Alibaba Amazon vs. Alibaba
AZZ: AZZ incorporated AZZ: AZZ incorporated AZZ: AZZ incorporated AZZ -- Aztec Manufacturing Co. AZZ -- Aztec Manufacturing Co. AZZ -- Aztec Manufacturing Co.
Solitario: Amaze-Zinc Value Solitario: Amaze-Zinc Value Solitario: Amaze-Zinc Value Razza. The rat that shows us the true way. Razza. The rat that shows us the true way. Razza. The rat that shows us the true way.